Sirio Pharma has launched the Sirio Institute for Anti-Ageing, which aims to advance anti-ageing science and develop and commercialise innovative products to promote healthy longevity.
The institute aims to provide consumers with the tools needed to develop competitive anti-ageing products.
As revealed at the Boao Health Food Science Conference & Expo, the institute will focus on cellular health, probiotics and gut health, muscle health and reproductive system health.
Established in 1993, Sirio Pharma Co., Ltd is a global nutraceutical contract development and manufacturing organisation.
Sirio Pharma specialises in the development and manufacturing of products including gummies, capsules, probiotics and liquids from its sites in Germany, the USA and China.
The institute will be led by Yu-Xuan Luyu, research assistant professor at the Institute of Advanced Biotechnology and the School of Medicine at the Southern University of Science and Technology.
Luyu said: “The Sirio Institute for Anti-Ageing will pioneer rigorous, evidence-based research and product development for our nutraceutical partners worldwide”.
The researcher added: “Our approach extends beyond merely delaying ageing manifestations, aiming to identify and modulate fundamental mechanisms of ageing.
“We will conduct cutting-edge research into innovative bioactive ingredients, synergistic formulations, delivery and stability optimisation protocols, and demonstrable consumer health benefits.”
In 2023, SIRIO acquired Best Formulations, in an effort to enhance its manufacturing capabilities and capacity – with a focus on bolstering its presence in North America.
